KDM8 and Patent ductus arteriosus: In agreement with this observation, Kdm8 and KDM8 knockdown in multiple murine and human PDA cell lines significantly increased sensitivity to the KRASG12D inhibitor MRTX1133 (Figures S6H and S6I).